FibroGen Market Cap

FibroGen has a market cap or net worth of 41.24 million as of January 23, 2025. Its market cap has decreased by -27.42% in one year.

Market Cap

41.24M

Enterprise Value

44.44M

Revenue

134.31M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.49

Market Cap Chart

Since November 14, 2014, FibroGen's market cap has decreased from 1.25B to 41.24M, a decrease of -96.69%. That is a compound annual growth rate of -28.42%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	43.36M	1.73%
Dec 31, 2024	42.62M	-37.71%
Dec 29, 2023	68.43M	-94.52%
Dec 30, 2022	1.25B	29.40%
Dec 31, 2021	965.40M	-60.95%
Dec 31, 2020	2.47B	-12.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	171.37B
GSK plc	55.43B
Haleon	33.25B
Smith & Nephew	9.04B
ConvaTec Group	4.92B
Hikma Pharmaceuticals	4.68B
HUTCHMED (China)	1.94B
Oxford Nanopore Technologies	1.48B

Market Cap Rankings